The Indiana Center for Biomedical Microscopy
With the completion of the Human Genome Project, the focus of
attention in biomedical research has shifted to understanding the
functions and interactions of proteins in cells. This shift corresponds to
revolutionary developments in optical microscopy and digital imaging
that provide investigators with unprecedented views of how cells
function and therapeutic agents work.
The Indiana Center for Biological Microscopy, with support from Indiana
Genomics Initiative, has developed into a world-class center for highresolution
biomedical imaging, providing state-of-the-art capabilities in
fluorescence, confocal and multi-photon microscopy.
The Center has assembled a unique synergistic team of cell biologists,
physicians, microscopists and computer engineers to realize the
potential of this technology for biomedical discovery and therapeutic
advances.
Researchers of the Center work closely with investigators from
academia and industry to apply this unique technology to understand
the biologicial basis of disease, and to develop effective therapies. In
addition to numerous collaborations with researchers throughout the
United States, collaborations are also currently underway with
international investigators from Australia, Sweden, Germany and
Canada. Industrial collaborators now include Eli Lilly, Abbott, Dow, ISIS
Pharmaceuticals, and Quark Pharmaceuticals.
For more information, visit: http://www.nephrology.iupui.edu/imaging/